NCT04551027

Brief Summary

The aim of this study is to assess the efficacy of a short term compensatory cognitive group intervention - the Compensatory Cognitive Training (CCT) among people with severe mental illnesses, receiving ambulatory treatment

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 17, 2020

Status Verified

September 1, 2020

Enrollment Period

1 year

First QC Date

August 14, 2020

Last Update Submit

September 16, 2020

Conditions

Keywords

compensatory cognitive treatmentmental illnesscognitive strategieseveryday functioning

Outcome Measures

Primary Outcomes (1)

  • Change from baseline functional capacity at 12 weeks : The Observed Tasks of Daily Living-Revised (OTDL-R)

    OTDL-R is an objective, performance-based evaluation of the subjects' ability to perform daily life activities in the following areas: Medication management, communication and finances management. The final score ranges from 0 (not independent) to 28 (independent).

    30 min duration at week 0 ; week 12

Secondary Outcomes (7)

  • Change from baseline cognitive functions at 12 weeks: The Cognitive Problems and Strategies Assessment (CPSA)

    10 min at week 0 ; week 12

  • Change from baseline severity of clinical symptoms at 12 weeks: Clinical Global Impression (CGI)

    week 0 ; week 12

  • Change from baseline cognitive functions at 12 weeks: The Neurobehavioral Cognitive Status Examination (COGNISTAT)

    20 min at week 0 ; week 12

  • Change from baseline cognitive functions at 12 weeks: Rey- Ostereich Complex Figure

    20 min at week 0 ; week 12

  • Change from baseline cognitive functions at 12 weeks: Trail Making Test A & B (TMT)

    3 min at week 0 ; week 12

  • +2 more secondary outcomes

Study Arms (2)

compensatory cognitive treatment

EXPERIMENTAL

compensatory cognitive treatment intervention, focusing on learning cognitive strategies to overcome cognitive deficits.

Behavioral: compensatory cognitive treatment

control group

NO INTERVENTION

standard ambulatory treatment

Interventions

a brief group compensatory cognitive intervention including 12 meetings of 1 hour in a group of five and focuses on these cognitive domains: prospective memory, vigilance and attention, memory and learning and executive functions

compensatory cognitive treatment

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • basic knowledge in Hebrew
  • diagnosed according to the ICD -10 with severe mental illness: schizophrenia, bipolar disease, schizoaffective disorder or major depression
  • Patients are treated with neuroleptic medication for at least four weeks.

You may not qualify if:

  • acquired neurological disorders including dementia and brain injury.
  • Developmental neurological disorders including developmental intellectual disability and autistic spectrum disorders.
  • Regular Electro convulsive therapy treatment with frequency of twice a month or more.
  • People to whom a guardian has been appointed
  • Current addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shalvata mental health center

Hod HaSharon, 4534708, Israel

Location

Related Publications (4)

  • Twamley EW, Burton CZ, Vella L. Compensatory cognitive training for psychosis: who benefits? Who stays in treatment? Schizophr Bull. 2011 Sep;37 Suppl 2(Suppl 2):S55-62. doi: 10.1093/schbul/sbr059.

    PMID: 21860048BACKGROUND
  • Twamley EW, Savla GN, Zurhellen CH, Heaton RK, Jeste DV. Development and Pilot Testing of a Novel Compensatory Cognitive Training Intervention for People with Psychosis. Am J Psychiatr Rehabil. 2008 Apr;11(2):144-163. doi: 10.1080/15487760801963678.

    PMID: 19198664BACKGROUND
  • Twamley EW, Thomas KR, Burton CZ, Vella L, Jeste DV, Heaton RK, McGurk SR. Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial. Schizophr Res. 2019 Jan;203:41-48. doi: 10.1016/j.schres.2017.08.005. Epub 2017 Aug 18.

    PMID: 28823720BACKGROUND
  • Twamley EW, Vella L, Burton CZ, Heaton RK, Jeste DV. Compensatory cognitive training for psychosis: effects in a randomized controlled trial. J Clin Psychiatry. 2012 Sep;73(9):1212-9. doi: 10.4088/JCP.12m07686. Epub 2012 Aug 7.

    PMID: 22939029BACKGROUND

Related Links

MeSH Terms

Conditions

Mood DisordersSchizophreniaPsychotic DisordersMental Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Ido Lurie, M.D

    Director of Adult clinic, Shalvata Mental Health Center

    PRINCIPAL INVESTIGATOR
  • Lena Lipskaya, P.H.D

    The Department of Occupational Therapy, The Stanley Steyer School of Health Professions, Sackler Faculty of Medicine,Tel Aviv University

    STUDY DIRECTOR

Central Study Contacts

Miryam Ben Zaken, B.O.T

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of adult clinic

Study Record Dates

First Submitted

August 14, 2020

First Posted

September 16, 2020

Study Start

September 1, 2020

Primary Completion

September 1, 2021

Study Completion

December 1, 2021

Last Updated

September 17, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations